| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Oxford Biomedica boost board
StockMarketWire.com
|
Oxford Biomedia has added a new non-executive director to its board, with Professor Dame Kay Davies joining on 1st March 2021.
Professor Davies is a world-leading human geneticist with a research focus on the molecular analysis of neuromuscular and neurological disease, particularly Duchenne muscular dystrophy.
She joins as non-independent director Martin Diggle steps down with immediate effect.
Oxford Biomedica non-executive chairman Dr Roch Doliveux said: 'It is an honour to have Professor Dame Kay Davies agree to join the Board and further augment our science and translational expertise as we continue to strengthen Oxford Biomedica's position as a leading gene and cell therapy company.
'I would like to thank Martin for his considerable time on the Board and the experience and support he has provided.'
At 1:38pm: (LON:OXB) Oxford Biomedica PLC share price was 0p at 860p
Story provided by StockMarketWire.com
|
|
|
|
|
|
